Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
285
-
Total 13F shares, excl. options
-
64M
-
Shares change
-
+2.08M
-
Total reported value, excl. options
-
$2.88B
-
Value change
-
+$82M
-
Put/Call ratio
-
0.48
-
Number of buys
-
147
-
Number of sells
-
-135
-
Price
-
$44.95
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2022
350 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2022.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64M shares
of 66.6M outstanding shares and own 96.21% of the company stock.
Largest 10 shareholders include FMR LLC (9.64M shares), BlackRock Inc. (6.35M shares), VANGUARD GROUP INC (6.13M shares), Capital World Investors (4.85M shares), Champlain Investment Partners, LLC (3.07M shares), EMINENCE CAPITAL, LP (2.78M shares), BROWN CAPITAL MANAGEMENT LLC (2.02M shares), STATE STREET CORP (1.83M shares), Bellevue Group AG (1.79M shares), and Capital International Investors (1.24M shares).
This table shows the top 285 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.